BIIB- Biogen Inc.

Name: Biogen Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Biogen Inc. (BIIB) has 15 insiders with recent SEC Form 4 filings, including 6 buys and 7 sells. BIIB is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Dorsa Caroline	31.0K	$6.28M	-
Dir	Rowinsky Eric K	24.3K	$4.93M	-
Dir	Sherwin Stephen A	13.7K	$2.77M	-
Dir	Mantas Jesus B	9.8K	$1.98M	-
Dir	Hawkins William A	8.9K	$1.79M	-

Activity

Buys and sells only

Transactions

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 7, 2021	Guindo Chirfi	Head Of Glob Prod Strat &Com	Sell	3,087	$440.00	$1,358,280.00	-51.4%	-17.3%	-49.2%
Jun 4, 2021	Posner Brian S59	Director	Sell	360	$274.17	$98,701.20	-4.6%	+17.3%	-29.9%
Feb 9, 2021	Mantas Jesus B	Director	Buy	898	$267.00	$239,766.00	+43.9%	-	-
Nov 30, 2020	Vounatsos Michel	Chief Executive Officer	Buy	3,100	$241.31	$748,046.74	+9.8%	-	-
Nov 4, 2020	Sandrock Alfred67	EVP, Research &Development	Sell	1,500	$350.00	$525,000.00	-10.3%	-	-
Mar 11, 2020	Sherwin Stephen A	Director	Sale+OE	2,434	$295.22	$718,573.56	-7.6%	-	-
Dec 2, 2019	Posner Brian S59	Director	Sell	1,055	$292.35	$308,429.25	-13.1%	-	-
May 2, 2019	Denner Alexander J66	Director	Buy	118,342	$229.94	$27,211,823.50	+6.9%	-	-
May 1, 2019	Vounatsos Michel	Chief Executive Officer	Buy	4,351	$231.48	$1,007,169.48	+26.1%	-	-
Mar 18, 2019	Pangia Robert W	Director	Sale+OE	6,114	$328.55	$2,008,754.70	-24.8%	-	-

← PrevPage 4Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC